Clinical Trials Browser

Mebendazole × Gastrointestinal × Clear all

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT04443049 2021-10-05

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Phase NA Unknown

170 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT03628079 2020-01-22

RepoMeb

Phase 1/2 Terminated

11 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Unknown Primary

NCT03925662 2019-04-24

Mebendazole as Adjuvant Treatment for Colon Cancer

Phase 3 Recruiting

40 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

METRICS

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

RepoMeb

Mebendazole as Adjuvant Treatment for Colon Cancer